Qiagen NV | QIA - Operating Expenses

Stock Price
41.12
Daily Change
0.72 1.78%
Monthly
-11.44%
Yearly
9.14%
Q1 Forecast
40.37

Qiagen NV reported $418.54M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 43.82M 16.98M Mar/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
argenx SE USD 776.99M 32.87M Sep/2025
Avita Medical AUD 29.57M 1.21M Jun/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Viatris USD 3.53B 128.7M Sep/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025